31 1 
Home Page  

  • SciELO

  • Google
  • SciELO
  • Google


Nutrición Hospitalaria

 ISSN 1699-5198 ISSN 0212-1611

SAN MAURO MARTIN, Ismael et al. Role of ApoA1 on High-Density Lipoprotein: an intervention with plant sterols in patients with hypercholesterolemia. []. , 31, 1, pp.494-499. ISSN 1699-5198.  https://dx.doi.org/10.3305/nh.2015.31.1.8147.

Background: Numerous studies have shown an inverse association between cholesterol´s concentration associated with High-Density Lipoprotein Cholesterol (HDL-C) and cardiovascular risk. The present study intends to investigate the possible relation between Apolipoprotein A (ApoA1) and HDL-C as a new strategy to reduce cardiovascular risk. Aim: was determine the effect of ApoA1 in cholesterol ´s metabolism through its influence on HDL-C in young adult population. Methods: One clinical trial, controlled, randomized, double-blind, providing a commercial milk, "Naturcol", with sterols for 3 weeks (n = 19) and placebo (n = 16). A questionnaire Ad Hoc was designed and a complete anthropometric study was made. SPSS 21.0 was used to analyse the data. Results: Significant differences were observed between sterol milk and placebo in a single marker, Low-Density Lipoprotein Cholesterol (LDL-C). A linear dispersion of data between HDL-C and ApoA1 was found, both at the beginning and end of the intervention (Person Correlation = 0.846 and 0.903, respectively). High dependency measures by linear regression (R2= 0.715 and 0.816, respectively) were observed. Conclusion: A significant relation between HDL-C and ApoA1 was proven. Taking into account the importance that HDL-C levels seem to have on cardiovascular health, ApoA1 is presented as an important clinical marker to improve heart function as well as to reduce cardiovascular risk.

: ApoA1; Cholesterol; Cardiovascular risk; Plant sterols; High-density lipoproteins (HDL-C).

        · |     · |     · ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License